Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol and Dexamethasone for Myelodysplastic Syndromes
NCT00030069Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Sep 2001
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of calcitriol in myelodysplastic syndrome (MDS), sponsored by University of Pittsburgh. Primary endpoints: Objective Response Rate and Maximum Tolerated Dose. Started Sep 2001; status: completed.
02
Drugs
calcitriol
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00030069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030069.